S Priya Narayanan

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Traumatic Brain Injury

Lipopolysaccharide Induced

Top Venues

Life (Basel, Switzerland)

Tissue barriers

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Abdulaziz H Alanazi, Shengshuai Shan, S Priya Narayanan, Payaningal R Somanath
Comparative Proteomic Analysis of Type 2 Diabetic versus Non-Diabetic Vitreous Fluids. Life (Basel, Switzerland) 14 (7) (2024)
Abdulaziz H Alanazi, Shengshuai Shan, S Priya Narayanan, Payaningal R Somanath
Comparative Proteomic Analysis of Type 2 Diabetic versus Non-Diabetic Vitreous Fluids. Life (Basel, Switzerland) 14 (7) (2024)
Abdullah Alhumaid, Fang Liu, Shengshuai Shan, Eissa Jafari, Nadia Nourin, Payaningal R Somanath, S Priya Narayanan
Spermine oxidase inhibitor, MDL 72527, reduced neovascularization, vascular permeability, and acrolein-conjugated proteins in a mouse model of ischemic retinopathy. Tissue barriers (2024)
Abdullah Alhumaid, Fang Liu, Shengshuai Shan, Eissa Jafari, Nadia Nourin, Payaningal R Somanath, S Priya Narayanan
Spermine oxidase inhibitor, MDL 72527, reduced neovascularization, vascular permeability, and acrolein-conjugated proteins in a mouse model of ischemic retinopathy. Tissue barriers (2024)
Abdulaziz H Alanazi, Shengshuai Shan, S Priya Narayanan, Payaningal R Somanath
Comparative Proteomic Analysis of Type 2 Diabetic versus Non-Diabetic Vitreous Fluids. Life (Basel, Switzerland) 14 (7) (2024)
Madhuri Rudraraju, Shengshuai Shan, Fang Liu, Jennifer Tyler, Ruth B Caldwell, Payaningal R Somanath, S Priya Narayanan
Pharmacological Modulation of β-Catenin Preserves Endothelial Barrier Integrity and Mitigates Retinal Vascular Permeability and Inflammation. Journal of clinical medicine 12 (22) (2023)
Fang Liu, Moaddey Alfarhan, Leanna Baker, Nidhi Shenoy, Yini Liao, Harry O Henry-Ojo, Payaningal R Somanath, S Priya Narayanan
Treatment with MDL 72527 Ameliorated Clinical Symptoms, Retinal Ganglion Cell Loss, Optic Nerve Inflammation, and Improved Visual Acuity in an Experimental Model of Multiple Sclerosis. Cells 11 (24) (2022)
Fang Liu, Moaddey Alfarhan, Leanna Baker, Nidhi Shenoy, Yini Liao, Harry O Henry-Ojo, Payaningal R Somanath, S Priya Narayanan
Treatment with MDL 72527 Ameliorated Clinical Symptoms, Retinal Ganglion Cell Loss, Optic Nerve Inflammation, and Improved Visual Acuity in an Experimental Model of Multiple Sclerosis. Cells 11 (24) (2022)
Fang Liu, Moaddey Alfarhan, Leanna Baker, Nidhi Shenoy, Yini Liao, Harry O Henry-Ojo, Payaningal R Somanath, S Priya Narayanan
Treatment with MDL 72527 Ameliorated Clinical Symptoms, Retinal Ganglion Cell Loss, Optic Nerve Inflammation, and Improved Visual Acuity in an Experimental Model of Multiple Sclerosis. Cells 11 (24) (2022)
Fang Liu, Moaddey Alfarhan, Leanna Baker, Nidhi Shenoy, Yini Liao, Harry O Henry-Ojo, Payaningal R Somanath, S Priya Narayanan
Treatment with MDL 72527 Ameliorated Clinical Symptoms, Retinal Ganglion Cell Loss, Optic Nerve Inflammation, and Improved Visual Acuity in an Experimental Model of Multiple Sclerosis. Cells 11 (24) (2022)
Fang Liu, Moaddey Alfarhan, Leanna Baker, Nidhi Shenoy, Yini Liao, Harry O Henry-Ojo, Payaningal R Somanath, S Priya Narayanan
Treatment with MDL 72527 Ameliorated Clinical Symptoms, Retinal Ganglion Cell Loss, Optic Nerve Inflammation, and Improved Visual Acuity in an Experimental Model of Multiple Sclerosis. Cells 11 (24) (2022)
Amritha A Candadai, Fang Liu, Abdelrahman Y Fouda, Moaddey Alfarhan, Chithra D Palani, Zhimin Xu, Ruth B Caldwell, S Priya Narayanan
Deletion of arginase 2 attenuates neuroinflammation in an experimental model of optic neuritis. PloS one 16 (3) (2021)